These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cryptosporidium parvum-Infected Neonatal Mice Show Gut Microbiota Remodelling Using High-Throughput Sequencing Analysis: Preliminary Results. Mammeri M; Chevillot A; Thomas M; Julien C; Auclair E; Pollet T; Polack B; Vallée I; Adjou KT Acta Parasitol; 2019 Jun; 64(2):268-275. PubMed ID: 30915719 [TBL] [Abstract][Full Text] [Related]
4. Probiotic Product Enhances Susceptibility of Mice to Cryptosporidiosis. Oliveira BCM; Widmer G Appl Environ Microbiol; 2018 Nov; 84(21):. PubMed ID: 30171003 [TBL] [Abstract][Full Text] [Related]
5. Specific increase of Fusobacterium in the faecal microbiota of neonatal calves infected with Cryptosporidium parvum. Ichikawa-Seki M; Motooka D; Kinami A; Murakoshi F; Takahashi Y; Aita J; Hayashi K; Tashibu A; Nakamura S; Iida T; Horii T; Nishikawa Y Sci Rep; 2019 Aug; 9(1):12517. PubMed ID: 31467354 [TBL] [Abstract][Full Text] [Related]
6. Case Report: The impact of severe cryptosporidiosis on the gut microbiota of a pediatric patient with CD40L immunodeficiency. Piazzesi A; Pane S; Russo A; Del Chierico F; Francalanci P; Cotugno N; Rossi P; Locatelli F; Palma P; Putignani L Front Cell Infect Microbiol; 2023; 13():1281440. PubMed ID: 37965266 [No Abstract] [Full Text] [Related]
7. Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cells. Hashim A; Mulcahy G; Bourke B; Clyne M Infect Immun; 2006 Jan; 74(1):99-107. PubMed ID: 16368962 [TBL] [Abstract][Full Text] [Related]
8. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia. Abdou AG; Harba NM; Afifi AF; Elnaidany NF Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034 [TBL] [Abstract][Full Text] [Related]
9. Induction of Inflammatory Responses in Splenocytes by Exosomes Released from Intestinal Epithelial Cells following Wang Y; Shen Y; Liu H; Yin J; Zhang XT; Gong AY; Chen X; Chen S; Mathy NW; Cao J; Chen XM Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642905 [No Abstract] [Full Text] [Related]
10. Curcumin mitigates Cryptosporidium parvum infection through modulation of gut microbiota and innate immune-related genes in immunosuppressed neonatal mice. Rahman SU; Zhou K; Zhou S; Sun T; Mi R; Huang Y; Han X; Gong H; Chen Z Microb Pathog; 2022 Mar; 164():105424. PubMed ID: 35092833 [TBL] [Abstract][Full Text] [Related]
11. Deprivation of dietary fiber enhances susceptibility of mice to cryptosporidiosis. Oliveira BCM; Bresciani KDS; Widmer G PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007411. PubMed ID: 31560681 [TBL] [Abstract][Full Text] [Related]
12. [Highly Active AntiRetroviral Therapy and cryptosporidiosis]. Morales Gomez MA Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695 [TBL] [Abstract][Full Text] [Related]
13. Microbiome diversity is a modifiable virulence factor for cryptosporidiosis. Hurle GR; Brainard J; Tyler KM Virulence; 2023 Dec; 14(1):2273004. PubMed ID: 37872759 [No Abstract] [Full Text] [Related]
14. Poly(I:C)-induced protection of neonatal mice against intestinal Cryptosporidium parvum infection requires an additional TLR5 signal provided by the gut flora. Lantier L; Drouet F; Guesdon W; Mancassola R; Metton C; Lo-Man R; Werts C; Laurent F; Lacroix-Lamandé S J Infect Dis; 2014 Feb; 209(3):457-67. PubMed ID: 24014881 [TBL] [Abstract][Full Text] [Related]
15. B cells are required for the induction of intestinal inflammatory lesions in TCRalpha-deficient mice persistently infected with Cryptosporidium parvum. Waters WR; Palmer MV; Wannemuehler MJ; Sacco RE; Harp JA J Parasitol; 2000 Oct; 86(5):1073-7. PubMed ID: 11128483 [TBL] [Abstract][Full Text] [Related]
16. Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes. Hashim A; Clyne M; Mulcahy G; Akiyoshi D; Chalmers R; Bourke B Infect Immun; 2004 Oct; 72(10):6125-31. PubMed ID: 15385517 [TBL] [Abstract][Full Text] [Related]
17. Substance P receptor antagonist reverses intestinal pathophysiological alterations occurring in a novel ex-vivo model of Cryptosporidium parvum infection of intestinal tissues derived from SIV-infected macaques. Garza A; Lackner A; Aye P; D'Souza M; Martin P; Borda J; Tweardy DJ; Weinstock J; Griffiths J; Robinson P J Med Primatol; 2008 Jun; 37(3):109-15. PubMed ID: 18547256 [TBL] [Abstract][Full Text] [Related]
18. Experimental infection with Cryptosporidium parvum IIaA21G1R1 subtype in immunosuppressed mice. Del Coco VF; Córdoba MA; Sidoti A; Santín M; Drut R; Basualdo JA Vet Parasitol; 2012 Dec; 190(3-4):411-7. PubMed ID: 22818787 [TBL] [Abstract][Full Text] [Related]
19. Effects of Cryptosporidium parvum infection on intestinal fungal microbiota in yaks (Bos grunniens). Lu S; Zou W; Chen X; Sun G; Cidan Y; Almutairi MH; Dunzhu L; Nazar M; Mehmood K; Zhu Y; Basang W; Li K Microb Pathog; 2023 Oct; 183():106322. PubMed ID: 37633503 [TBL] [Abstract][Full Text] [Related]
20. Treatment with agmatine inhibits Cryptosporidium parvum infection in infant mice. Moore D; Waters WR; Wannemuehler MJ; Harp JA J Parasitol; 2001 Feb; 87(1):211-3. PubMed ID: 11227893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]